Cargando…

Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease

Detalles Bibliográficos
Autores principales: An, Tai Joon, Lee, Ye Jin, Park, Ji Eun, Lee, Eung Gu, Kim, Youlim, Kang, Sung-Yoon, Joo, Hyonsoo, Choi, Joon Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537655/
https://www.ncbi.nlm.nih.gov/pubmed/35950320
http://dx.doi.org/10.4046/trd.2022.0072
_version_ 1784803253672738816
author An, Tai Joon
Lee, Ye Jin
Park, Ji Eun
Lee, Eung Gu
Kim, Youlim
Kang, Sung-Yoon
Joo, Hyonsoo
Choi, Joon Young
author_facet An, Tai Joon
Lee, Ye Jin
Park, Ji Eun
Lee, Eung Gu
Kim, Youlim
Kang, Sung-Yoon
Joo, Hyonsoo
Choi, Joon Young
author_sort An, Tai Joon
collection PubMed
description
format Online
Article
Text
id pubmed-9537655
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Korean Academy of Tuberculosis and Respiratory Diseases
record_format MEDLINE/PubMed
spelling pubmed-95376552022-10-17 Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease An, Tai Joon Lee, Ye Jin Park, Ji Eun Lee, Eung Gu Kim, Youlim Kang, Sung-Yoon Joo, Hyonsoo Choi, Joon Young Tuberc Respir Dis (Seoul) Letter to the Editor The Korean Academy of Tuberculosis and Respiratory Diseases 2022-10 2022-08-11 /pmc/articles/PMC9537655/ /pubmed/35950320 http://dx.doi.org/10.4046/trd.2022.0072 Text en Copyright © 2022 The Korean Academy of Tuberculosis and Respiratory Diseases https://creativecommons.org/licenses/by-nc/4.0/It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ).
spellingShingle Letter to the Editor
An, Tai Joon
Lee, Ye Jin
Park, Ji Eun
Lee, Eung Gu
Kim, Youlim
Kang, Sung-Yoon
Joo, Hyonsoo
Choi, Joon Young
Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease
title Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease
title_full Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease
title_fullStr Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease
title_full_unstemmed Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease
title_short Benefits of Early Systemic Corticosteroid in Clinical Deterioration of Post–COVID-19 Interstitial Lung Disease
title_sort benefits of early systemic corticosteroid in clinical deterioration of post–covid-19 interstitial lung disease
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537655/
https://www.ncbi.nlm.nih.gov/pubmed/35950320
http://dx.doi.org/10.4046/trd.2022.0072
work_keys_str_mv AT antaijoon benefitsofearlysystemiccorticosteroidinclinicaldeteriorationofpostcovid19interstitiallungdisease
AT leeyejin benefitsofearlysystemiccorticosteroidinclinicaldeteriorationofpostcovid19interstitiallungdisease
AT parkjieun benefitsofearlysystemiccorticosteroidinclinicaldeteriorationofpostcovid19interstitiallungdisease
AT leeeunggu benefitsofearlysystemiccorticosteroidinclinicaldeteriorationofpostcovid19interstitiallungdisease
AT kimyoulim benefitsofearlysystemiccorticosteroidinclinicaldeteriorationofpostcovid19interstitiallungdisease
AT kangsungyoon benefitsofearlysystemiccorticosteroidinclinicaldeteriorationofpostcovid19interstitiallungdisease
AT joohyonsoo benefitsofearlysystemiccorticosteroidinclinicaldeteriorationofpostcovid19interstitiallungdisease
AT choijoonyoung benefitsofearlysystemiccorticosteroidinclinicaldeteriorationofpostcovid19interstitiallungdisease